Overview

Azithromycin Plus Chloroquine Versus Artemether-Lumefantrine For The Treatment Of Uncomplicated P. Falciparum Malaria In Children In Africa

Status:
Completed

Trial end date:
2010-09-01

Target enrollment:

Participant gender:

Summary

The primary objective is to confirm the hypothesis that azithromycin used in combination with chloroquine is non-inferior to artemether- Lumefantrine for the treatment of symptomatic, uncomplicated malaria due to P. falciparum in children in African countries.

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

Pfizer

Treatments:

Artemether
Artemether-lumefantrine combination
Artemether, Lumefantrine Drug Combination
Artemisinins
Azithromycin
Chloroquine
Chloroquine diphosphate
Lumefantrine